In diabetes models, BRD3308 can inhibit the synthesis and secretion of inflammatory factors and reduce pancreatic β-cell apoptosis via selective inhibition of HDAC3 [154].In addition, several selective HDAC3 inhibitors derived from natural compounds have also been found [155, 156]. This evidence concerns the gene HDAC3 and diabetes mellitus.